Global Metabolic Biomarker Testing Market Research Report 2023

In medicine, a biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism.

The global Metabolic Biomarker Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Biomarkers are useful in a number of ways, including measuring the progress of disease, evaluating the most effective therapeutic regimes for a particular cancer type, and establishing long-term susceptibility to cancer or its recurrence. The parameter can be chemical, physical or biological. Biomarkers help in early diagnosis, disease prevention, drug target identification, drug response etc. Several biomarkers have been identified for many diseases such as serum LDL for cholesterol, blood pressure, and P53 gene[4]and MMPs [5] as tumor markers for cancer. Biomarkers are also seen as the key to personalised medicine, treatments individually tailored to specific patients for highly efficient intervention in disease processes. Often, such biomarkers indicate changes in metabolic processes.

This report aims to provide a comprehensive presentation of the global market for Metabolic Biomarker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolic Biomarker Testing.

The Metabolic Biomarker Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Metabolic Biomarker Testing market comprehensively. Regional market sizes, concerning products by technology, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Metabolic Biomarker Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by technology, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Technology

1.2.1 Global Metabolic Biomarker Testing Market Size Growth Rate by Technology: 2018 VS 2022 VS 2029

1.2.2 Separation Techniques

1.2.3 Detection Techniques

1.2.4 Others

1.3 Market by Application

1.3.1 Global Metabolic Biomarker Testing Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Drug Discovery

1.3.3 Nutrigenomics

1.3.4 Toxicology Testing

1.3.5 Personalized Medicine

1.3.6 Functional Genomics

1.3.7 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Metabolic Biomarker Testing Market Perspective (2018-2029)

2.2 Metabolic Biomarker Testing Growth Trends by Region

2.2.1 Global Metabolic Biomarker Testing Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Metabolic Biomarker Testing Historic Market Size by Region (2018-2023)

2.2.3 Metabolic Biomarker Testing Forecasted Market Size by Region (2024-2029)

2.3 Metabolic Biomarker Testing Market Dynamics

2.3.1 Metabolic Biomarker Testing Industry Trends

2.3.2 Metabolic Biomarker Testing Market Drivers

2.3.3 Metabolic Biomarker Testing Market Challenges

2.3.4 Metabolic Biomarker Testing Market Restraints

3.1 Global Top Metabolic Biomarker Testing Players by Revenue

3.1.1 Global Top Metabolic Biomarker Testing Players by Revenue (2018-2023)

3.1.2 Global Metabolic Biomarker Testing Revenue Market Share by Players (2018-2023)

3.2 Global Metabolic Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Metabolic Biomarker Testing Revenue

3.4 Global Metabolic Biomarker Testing Market Concentration Ratio

3.4.1 Global Metabolic Biomarker Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Metabolic Biomarker Testing Revenue in 2022

3.5 Metabolic Biomarker Testing Key Players Head office and Area Served

3.6 Key Players Metabolic Biomarker Testing Product Solution and Service

3.7 Date of Enter into Metabolic Biomarker Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Metabolic Biomarker Testing Historic Market Size by Technology (2018-2023)

4.2 Global Metabolic Biomarker Testing Forecasted Market Size by Technology (2024-2029)

5.1 Global Metabolic Biomarker Testing Historic Market Size by Application (2018-2023)

5.2 Global Metabolic Biomarker Testing Forecasted Market Size by Application (2024-2029)

6.1 North America Metabolic Biomarker Testing Market Size (2018-2029)

6.2 North America Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Metabolic Biomarker Testing Market Size by Country (2018-2023)

6.4 North America Metabolic Biomarker Testing Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Metabolic Biomarker Testing Market Size (2018-2029)

7.2 Europe Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Metabolic Biomarker Testing Market Size by Country (2018-2023)

7.4 Europe Metabolic Biomarker Testing Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Metabolic Biomarker Testing Market Size (2018-2029)

8.2 Asia-Pacific Metabolic Biomarker Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2018-2023)

8.4 Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Metabolic Biomarker Testing Market Size (2018-2029)

9.2 Latin America Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Metabolic Biomarker Testing Market Size by Country (2018-2023)

9.4 Latin America Metabolic Biomarker Testing Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Metabolic Biomarker Testing Market Size (2018-2029)

10.2 Middle East & Africa Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2018-2023)

10.4 Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Agilent Technologies

11.1.1 Agilent Technologies Company Detail

11.1.2 Agilent Technologies Business Overview

11.1.3 Agilent Technologies Metabolic Biomarker Testing Introduction

11.1.4 Agilent Technologies Revenue in Metabolic Biomarker Testing Business (2018-2023)

11.1.5 Agilent Technologies Recent Development

11.2 Bio-Rad Laboratories

11.2.1 Bio-Rad Laboratories Company Detail

11.2.2 Bio-Rad Laboratories Business Overview

11.2.3 Bio-Rad Laboratories Metabolic Biomarker Testing Introduction

11.2.4 Bio-Rad Laboratories Revenue in Metabolic Biomarker Testing Business (2018-2023)

11.2.5 Bio-Rad Laboratories Recent Development

11.3 Bruker

11.3.1 Bruker Company Detail

11.3.2 Bruker Business Overview

11.3.3 Bruker Metabolic Biomarker Testing Introduction

11.3.4 Bruker Revenue in Metabolic Biomarker Testing Business (2018-2023)

11.3.5 Bruker Recent Development

11.4 Danaher

11.4.1 Danaher Company Detail

11.4.2 Danaher Business Overview

11.4.3 Danaher Metabolic Biomarker Testing Introduction

11.4.4 Danaher Revenue in Metabolic Biomarker Testing Business (2018-2023)

11.4.5 Danaher Recent Development

11.5 Waters Corporation

11.5.1 Waters Corporation Company Detail

11.5.2 Waters Corporation Business Overview

11.5.3 Waters Corporation Metabolic Biomarker Testing Introduction

11.5.4 Waters Corporation Revenue in Metabolic Biomarker Testing Business (2018-2023)

11.5.5 Waters Corporation Recent Development

11.6 Thermo Fisher Scientific

11.6.1 Thermo Fisher Scientific Company Detail

11.6.2 Thermo Fisher Scientific Business Overview

11.6.3 Thermo Fisher Scientific Metabolic Biomarker Testing Introduction

11.6.4 Thermo Fisher Scientific Revenue in Metabolic Biomarker Testing Business (2018-2023)

11.6.5 Thermo Fisher Scientific Recent Development

11.7 Biocrates Life Sciences

11.7.1 Biocrates Life Sciences Company Detail

11.7.2 Biocrates Life Sciences Business Overview

11.7.3 Biocrates Life Sciences Metabolic Biomarker Testing Introduction

11.7.4 Biocrates Life Sciences Revenue in Metabolic Biomarker Testing Business (2018-2023)

11.7.5 Biocrates Life Sciences Recent Development

11.8 Human Metabolome Technologies

11.8.1 Human Metabolome Technologies Company Detail

11.8.2 Human Metabolome Technologies Business Overview

11.8.3 Human Metabolome Technologies Metabolic Biomarker Testing Introduction

11.8.4 Human Metabolome Technologies Revenue in Metabolic Biomarker Testing Business (2018-2023)

11.8.5 Human Metabolome Technologies Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Metabolic Biomarker Testing Market Size Growth Rate by Technology (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Separation Techniques

    Table 3. Key Players of Detection Techniques

    Table 4. Key Players of Others

    Table 5. Global Metabolic Biomarker Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Metabolic Biomarker Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Metabolic Biomarker Testing Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Metabolic Biomarker Testing Market Share by Region (2018-2023)

    Table 9. Global Metabolic Biomarker Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Metabolic Biomarker Testing Market Share by Region (2024-2029)

    Table 11. Metabolic Biomarker Testing Market Trends

    Table 12. Metabolic Biomarker Testing Market Drivers

    Table 13. Metabolic Biomarker Testing Market Challenges

    Table 14. Metabolic Biomarker Testing Market Restraints

    Table 15. Global Metabolic Biomarker Testing Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Metabolic Biomarker Testing Market Share by Players (2018-2023)

    Table 17. Global Top Metabolic Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Biomarker Testing as of 2022)

    Table 18. Ranking of Global Top Metabolic Biomarker Testing Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Metabolic Biomarker Testing Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Metabolic Biomarker Testing Product Solution and Service

    Table 22. Date of Enter into Metabolic Biomarker Testing Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Metabolic Biomarker Testing Market Size by Technology (2018-2023) & (US$ Million)

    Table 25. Global Metabolic Biomarker Testing Revenue Market Share by Technology (2018-2023)

    Table 26. Global Metabolic Biomarker Testing Forecasted Market Size by Technology (2024-2029) & (US$ Million)

    Table 27. Global Metabolic Biomarker Testing Revenue Market Share by Technology (2024-2029)

    Table 28. Global Metabolic Biomarker Testing Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Metabolic Biomarker Testing Revenue Market Share by Application (2018-2023)

    Table 30. Global Metabolic Biomarker Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Metabolic Biomarker Testing Revenue Market Share by Application (2024-2029)

    Table 32. North America Metabolic Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Metabolic Biomarker Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Metabolic Biomarker Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Metabolic Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Metabolic Biomarker Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Metabolic Biomarker Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Metabolic Biomarker Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Metabolic Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Metabolic Biomarker Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Metabolic Biomarker Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Metabolic Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Agilent Technologies Company Detail

    Table 48. Agilent Technologies Business Overview

    Table 49. Agilent Technologies Metabolic Biomarker Testing Product

    Table 50. Agilent Technologies Revenue in Metabolic Biomarker Testing Business (2018-2023) & (US$ Million)

    Table 51. Agilent Technologies Recent Development

    Table 52. Bio-Rad Laboratories Company Detail

    Table 53. Bio-Rad Laboratories Business Overview

    Table 54. Bio-Rad Laboratories Metabolic Biomarker Testing Product

    Table 55. Bio-Rad Laboratories Revenue in Metabolic Biomarker Testing Business (2018-2023) & (US$ Million)

    Table 56. Bio-Rad Laboratories Recent Development

    Table 57. Bruker Company Detail

    Table 58. Bruker Business Overview

    Table 59. Bruker Metabolic Biomarker Testing Product

    Table 60. Bruker Revenue in Metabolic Biomarker Testing Business (2018-2023) & (US$ Million)

    Table 61. Bruker Recent Development

    Table 62. Danaher Company Detail

    Table 63. Danaher Business Overview

    Table 64. Danaher Metabolic Biomarker Testing Product

    Table 65. Danaher Revenue in Metabolic Biomarker Testing Business (2018-2023) & (US$ Million)

    Table 66. Danaher Recent Development

    Table 67. Waters Corporation Company Detail

    Table 68. Waters Corporation Business Overview

    Table 69. Waters Corporation Metabolic Biomarker Testing Product

    Table 70. Waters Corporation Revenue in Metabolic Biomarker Testing Business (2018-2023) & (US$ Million)

    Table 71. Waters Corporation Recent Development

    Table 72. Thermo Fisher Scientific Company Detail

    Table 73. Thermo Fisher Scientific Business Overview

    Table 74. Thermo Fisher Scientific Metabolic Biomarker Testing Product

    Table 75. Thermo Fisher Scientific Revenue in Metabolic Biomarker Testing Business (2018-2023) & (US$ Million)

    Table 76. Thermo Fisher Scientific Recent Development

    Table 77. Biocrates Life Sciences Company Detail

    Table 78. Biocrates Life Sciences Business Overview

    Table 79. Biocrates Life Sciences Metabolic Biomarker Testing Product

    Table 80. Biocrates Life Sciences Revenue in Metabolic Biomarker Testing Business (2018-2023) & (US$ Million)

    Table 81. Biocrates Life Sciences Recent Development

    Table 82. Human Metabolome Technologies Company Detail

    Table 83. Human Metabolome Technologies Business Overview

    Table 84. Human Metabolome Technologies Metabolic Biomarker Testing Product

    Table 85. Human Metabolome Technologies Revenue in Metabolic Biomarker Testing Business (2018-2023) & (US$ Million)

    Table 86. Human Metabolome Technologies Recent Development

    Table 87. Research Programs/Design for This Report

    Table 88. Key Data Information from Secondary Sources

    Table 89. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Metabolic Biomarker Testing Market Size Comparison by Technology (2023-2029) & (US$ Million)

    Figure 2. Global Metabolic Biomarker Testing Market Share by Technology: 2022 VS 2029

    Figure 3. Separation Techniques Features

    Figure 4. Detection Techniques Features

    Figure 5. Others Features

    Figure 6. Global Metabolic Biomarker Testing Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Metabolic Biomarker Testing Market Share by Application: 2022 VS 2029

    Figure 8. Drug Discovery Case Studies

    Figure 9. Nutrigenomics Case Studies

    Figure 10. Toxicology Testing Case Studies

    Figure 11. Personalized Medicine Case Studies

    Figure 12. Functional Genomics Case Studies

    Figure 13. Others Case Studies

    Figure 14. Metabolic Biomarker Testing Report Years Considered

    Figure 15. Global Metabolic Biomarker Testing Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 16. Global Metabolic Biomarker Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 17. Global Metabolic Biomarker Testing Market Share by Region: 2022 VS 2029

    Figure 18. Global Metabolic Biomarker Testing Market Share by Players in 2022

    Figure 19. Global Top Metabolic Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Biomarker Testing as of 2022)

    Figure 20. The Top 10 and 5 Players Market Share by Metabolic Biomarker Testing Revenue in 2022

    Figure 21. North America Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. North America Metabolic Biomarker Testing Market Share by Country (2018-2029)

    Figure 23. United States Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Canada Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Metabolic Biomarker Testing Market Share by Country (2018-2029)

    Figure 27. Germany Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. France Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. U.K. Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Italy Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Russia Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Nordic Countries Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Metabolic Biomarker Testing Market Share by Region (2018-2029)

    Figure 35. China Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Japan Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. South Korea Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Southeast Asia Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. India Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Australia Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Metabolic Biomarker Testing Market Share by Country (2018-2029)

    Figure 43. Mexico Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Brazil Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Metabolic Biomarker Testing Market Share by Country (2018-2029)

    Figure 47. Turkey Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Saudi Arabia Metabolic Biomarker Testing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Agilent Technologies Revenue Growth Rate in Metabolic Biomarker Testing Business (2018-2023)

    Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Metabolic Biomarker Testing Business (2018-2023)

    Figure 51. Bruker Revenue Growth Rate in Metabolic Biomarker Testing Business (2018-2023)

    Figure 52. Danaher Revenue Growth Rate in Metabolic Biomarker Testing Business (2018-2023)

    Figure 53. Waters Corporation Revenue Growth Rate in Metabolic Biomarker Testing Business (2018-2023)

    Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Metabolic Biomarker Testing Business (2018-2023)

    Figure 55. Biocrates Life Sciences Revenue Growth Rate in Metabolic Biomarker Testing Business (2018-2023)

    Figure 56. Human Metabolome Technologies Revenue Growth Rate in Metabolic Biomarker Testing Business (2018-2023)

    Figure 57. Bottom-up and Top-down Approaches for This Report

    Figure 58. Data Triangulation

    Figure 59. Key Executives Interviewed